CORE--DI VIRAL VECTOR
CORE--DI VIRAL VECTOR
批准号:
6302740
负责人:
MICHEAL M LAI
金额:
$18.61万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2001-03-31
中文摘要
神经病理学核心为所有四个项目提供必要的服务。
详细说明项目中的组织病理学变化,是否由于DI
载体驱动的新基因表达或感染分析,
免疫缺陷小鼠,是许多建议的关键终点。
实验组织标本由核心采集,作为
实验程序。动物很少会专门
采集该岩心的样品。这些程序
(塑料包埋和EM),需要灌注。组织次数
采集是由各个实验决定的,
核心导演。核心研究助理负责
所有组织的处理、切片和染色。常规检查,
在大多数动物身上进行的测试包括H&E,luxol坚牢蓝,
髓鞘和免疫过氧化物酶测定用于病毒分布
AG.针对特定细胞亚型的特殊染色,
细胞因子,原位杂交等,是由个人决定的
实验,也是质量控制和时间表结合
和核心主管Epon嵌入材料和冷冻选择是
也由核心处理。我们很幸运能保留这些服务
在过去的8年里,他在所有建议的经验,
技术,并已成为我们正在进行的研究的宝贵资产
努力根据实验的性质,载玻片可以是
由核心主任筛选或由希尔顿博士盲读
或两者关键实验的盲态阅读排除了研究者
bias.
在过去,我们已经发布了所有建议的精确协议,
技术,因此预计没有困难。一个协议
值得注意的变化是使用命名为RIP的鼠mAb用于
少突胶质细胞染色。该mAb对少突胶质细胞具有特异性,
识别的大鼠和小鼠来源的少突胶质细胞,
福尔马林固定或冷冻切片。含RIP mAb的上清液
由Regeneron Inc.因为他们无法向我们提供
直接用杂交瘤。
英文摘要
The neuropathology core provides services essential to all four projects.
Ad detailed in the projects histopathological changes, whether due to DI
vector driven expression of novel genes or analysis of infection in
immunodeficient mice, is the critical end point for many of the proposed
experiments. Tissue specimens are acquired by the core as part of the
experimental procedures. Animals are rarely dedicated solely to
acquisition of samples for this core. Exceptions are those procedures
(plastic embedding and EM) which require perfusion. Times of tissue
acquisition are dictated by the individual experiments and are coordinated
by the core director. The core research associate is responsible for
processing, sectioning and staining of all tissues. Routine examinations,
carried out on the majority of animals include H&E, luxol fast blue of
myelin and immunoperoxidase determinations for the distribution of viral
Ag. Special stains for specific subtypes of cells, expression of
cytokines, in situ hybridizations etc., are dictated by the individual
experiments and are also quality controlled and schedule in conjunction
with the core director. Epon embedded materials and frozen selections are
also processed by the core. We are fortunate to have retained the services
of Wen for the past 8 years. He has experience in all of the proposed
techniques and has been an invaluable asset to our ongoing research
efforts. Depending upon the nature of the experiments, slides are either
screened by the core director or read in a blinded fashion by Dr. Hilton
or both. Blinded reading of critical experiments eliminates investigator
bias.
In the past we have published precise protocols for all of the proposed
techniques and therefore no difficulties are anticipated. One protocol
change worthy of note is the use of the murine mAb designated RIP for
staining of oligodendroglia. This mAb is specific for oligodendroglia and
recognized oligodendroglia of both rat and mouse origins and can be used
on formalin fixed or frozen sections. Supernatants containing the RIP mAb
are kindly provided by Regeneron Inc. since they are unable to provide us
directly with the hybridoma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VIRUS ENTRY AS A DETERMINANT OF MOUSE HEPATITIS VIRUS NEUROTROPISM
-
批准号:6585580
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2002
-
负责人:MICHEAL M LAI
-
依托单位:
CORE--DI VIRAL VECTOR
-
批准号:6585583
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2002
-
负责人:MICHEAL M LAI
-
依托单位:
VIRUS ENTRY AS A DETERMINANT OF MOUSE HEPATITIS VIRUS NEUROTROPISM
-
批准号:6442598
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2001
-
负责人:MICHEAL M LAI
-
依托单位:
CORE--DI VIRAL VECTOR
-
批准号:6442601
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2001
-
负责人:MICHEAL M LAI
-
依托单位:
VIRUS ENTRY AS A DETERMINANT OF MOUSE HEPATITIS VIRUS NEUROTROPISM
-
批准号:6302737
-
项目类别:
-
资助金额:$18.61万
-
财政年份:2000
-
负责人:MICHEAL M LAI
-
依托单位:
VIRUS ENTRY AS A DETERMINANT OF MOUSE HEPATITIS VIRUS NEUROTROPISM
-
批准号:6112183
-
项目类别:
-
资助金额:$18.61万
-
财政年份:1999
-
负责人:MICHEAL M LAI
-
依托单位:
CORE--DI VIRAL VECTOR
-
批准号:6112186
-
项目类别:
-
资助金额:$18.61万
-
财政年份:1999
-
负责人:MICHEAL M LAI
-
依托单位:
CORE--DI VIRAL VECTOR
-
批准号:6273673
-
项目类别:
-
资助金额:$18.21万
-
财政年份:1998
-
负责人:MICHEAL M LAI
-
依托单位:
VIRUS ENTRY AS A DETERMINANT OF MOUSE HEPATITIS VIRUS NEUROTROPISM
-
批准号:6273670
-
项目类别:
-
资助金额:$18.21万
-
财政年份:1998
-
负责人:MICHEAL M LAI
-
依托单位:
海外基金